Myriad Genetics survey: Women have widespread confusion and misconceptions about ovarian cancer screening

Myriad Genetics, Inc., a leader in genetic testing and precision medicine, today revealed new nationwide survey results indicating widespread confusion and misconceptions about ovarian cancer screening among a majority of women.

Canadian Psychedelic Users Self-Medicating, But Few Discuss with Healthcare Providers, Says Recent Survey | Psychedelic Spotlight

A recent survey published in the Journal of Psychoactive Drugs which investigated the Relationship Between Naturalistic Psychedelic Use and Clinical Care in Canada, found that more

August 21, 2023

ChatGPT can be useful for preoperative MRI diagnosis of brain tumors

As artificial intelligence advances, its uses and capabilities in real-world applications continue to reach new heights that may even surpass human expertise

October 1, 2024

High GATA6 expression predicts improved outcomes in pancreatic cancer

This new review article highlights the crucial role of GATA6, a transcription factor, in pancreatic ductal adenocarcinoma (PDA). The article explores GATA6’s dual role in

February 24, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.